Old-hat investors Alta Partners snag $275M for their newest next-gen fund, more than double the first iteration from 2018
Alta Partners has seen it all over the course of more than 20 years in biotech investing, but that doesn’t mean they aren’t still looking …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
